Independent evaluator knowledge of treatment in a multicenter comparative treatment study of panic disorder

Neuropsychopharmacology

Volumn 29, Issue 3, 2004, Pages 612-618

  Roll, David ^a   Ray, Susan E ^b   Marcus, Sue M ^c   Passarelli, Vincent ^a   Money, Roy ^d   Barlow, David H ^e   Woods, Scott W ^d   Shear, M Katherine ^f   Gorman, Jack M ^c  

^a LONG ISLAND UNIVERSITY   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Behavior theraphy; Clinical research protocols; Double blind method; Pharmacotheraphy; Research methodology

Indexed keywords

IMIPRAMINE;

ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HUMAN; INTERMETHOD COMPARISON; INTERVIEW; METHODOLOGY; MULTICENTER STUDY; PANIC; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

DOUBLE-BLIND METHOD; HUMANS; MULTICENTER STUDIES; OBSERVER VARIATION; PANIC DISORDER; RANDOMIZED CONTROLLED TRIALS;

EID: 1642418863     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300373     Document Type: Article

References (20)

1. Bakker A, Spinhoven P, Anton J, Dick M, van Dyck R (1999). Double-blindness procedure did not mask giving of medication in panic disorder. J Aff Dis 54: 189-192.
2. Barlow D, Gorman J, Shear K, Woods S (2000). Cognitive-behavioral therapy, imipramine, or their combination for panic disorder. JAMA 283: 2529-2536.
3. Basoglu M, Marks I, Livanou M, Swinson R (1997). Double-blindness procedures, rater blindness, and ratings outcome: observations from a controlled trial. Arch Gen Psychiatry 54: 744-748.
4. Beatty W (1972). How blind is blind? A simple procedure for estimating observer naivete. Psychol Bull 78: 70-71.
5. Carroll K, Rounsaville B, Nich C (1994). Blind man's bluff: effectiveness and significance of psychotherapy and pharmacotherapy. blinding procedures in a clinical trial. J Consult Clin Psychol 62: 276-280.
6. Chambless DL, Hollon SD (1998). Defining empirically supported therapies. J Consult Clin Psychol 66: 7-18.
7. DiNardo PA, Barlow DH (1988). Anxiety Disorders Interview Schedule-Revised (ADIS-R). Graywind Publications Inc/The Psychological Corporation: San Antonio, TX.
8. Double D (1995). Unblinding in trials of the withdrawal of anticholinergic agents in patients maintained on neuroleptics. J Nerv Ment Dis 183: 599-602.
9. Fisher S, Greenberg R (1993). How sound is the double-blind design for evaluating psychotropic drugs? J Nerv Ment Dis 181: 345-350.
10. Gibbons RD (2000). Mixed-effects models for mental health services research. Health Services Outcomes Res Methodol 1: 91-129.
11. Guy W (1976). ECDEU Assessment Manual for Psychopharmacology, Revised. US Government Printing Office: DHEW Publication ADM: Washington DC, 76-338.
12. Hedeker D, Gibbons RD (1996). MIXOR: a computer program for mixed-effects ordinal regression analysis. Comput Meth Programs Biomed 49: 157-176.
13. Kendall PC (1998). Empirically supported psychological therapies. J Consult Clin Psychol 66: 3-6.
14. Klein DF (1994). The utility of guidelines and algorithms for practice. Psychiatr Ann 362-367.
15. Marks I, Gray S, Cohen D, Hill R, Mawson D, Ramm E, Stern R (1983). Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework. Arch Gen Psychiatry 40: 153-162.
16. Schneier FR, Goetz D, Campeas R, Fallon B, Marshall R, Liebowitz MR (1998). Placebo-controlled trial of moclobemide in social phobia. Br J Psychiatry 172: 70-77.
17. Seligman MEP (1995). The effectiveness of psychotherapy: the consumer reports survey. Am Psychol 50: 965-974.
18. Shear MK, Brown TA, Barlow DH, Money R, Sholomshas DE, Woods SW, Gorman JM, Papp LA (1997). Multicenter collaborative panic disorder severity scale. Am J Psychiatry 154: 1571-1575.
19. Spitzer RL, Williams JBW, Gibbon M, First MB (1988). Structured Clinical Interview for DSM-IIIR: Patient Version (SCID-P). New York Psychiatric Institute: New York.
20. Woods SW, Sholomskas DE, Shear MK, Gorman JM, Barlow DH, Goddard AW et al. (1998). Efficient allocation of patients to treatment cells in clinical trials with more than two treatment conditions. Am J Psychiatry 155: 1446-1448.